Sunheang Shin

A live, attenuated recombinant West Nile virus vaccine.

S. Green, F. Ennis, F. Guirakhoo, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Mass Vaccination with a New, Less Expensive Oral Cholera Vaccine Using Public Health Infrastructure in India: The Odisha Model

G. Nair, H. Khuntia, A. S. Kerketta, 2014, PLoS neglected tropical diseases.

New-generation vaccines against cholera

G. Nair, J. Clemens, S. Shin, 2011, Nature Reviews Gastroenterology &Hepatology.

Oral vaccines against cholera.

J. Clemens, S. Desai, S. Shin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

11 – Cholera vaccines

C. Tacket, J. Kaper, J. Clemens, 2013 .

Safety of the Recombinant Cholera Toxin B Subunit, Killed Whole-Cell (rBS-WC) Oral Cholera Vaccine in Pregnancy

M. Kieny, D. Sack, R. Hutubessy, 2012, PLoS neglected tropical diseases.

New approaches to the assessment of vaccine herd protection in clinical trials.

Mohammad Ali, J. Clemens, S. Shin, 2011, The Lancet. Infectious diseases.

Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam

S. Shin, N. Alexander, A. Riewpaiboon, 2016, BMC Public Health.

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

F. Guirakhoo, T. Monath, R. A. Beck, 2005, Biologicals : journal of the International Association of Biological Standardization.